Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


27.05.2019

3 Acta Neurol Scand
2 Ann Neurol
2 Can J Neurol Sci
1 J Clin Invest
1 J Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. GASCOYNE CR, Simpson S Jr, Chen J, van der Mei I, et al
    Modifiable factors associated with depression and anxiety in multiple sclerosis.
    Acta Neurol Scand. 2019 May 23. doi: 10.1111/ane.13132.
    PubMed     Text format     Abstract available

  2. DE FLON P, Laurell K, Sundstrom P, Blennow K, et al
    Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
    Acta Neurol Scand. 2019;139:462-468.
    PubMed     Text format     Abstract available

  3. AXELSSON M, Dubuisson N, Novakova L, Malmestrom C, et al
    Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
    Acta Neurol Scand. 2019;139:422-427.
    PubMed     Text format     Abstract available


    Ann Neurol

  4. ZAHEDNASAB H, Harirchian MH, Karampoor S, Keyvani H, et al
    MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25037.
    PubMed     Text format    

  5. FISSOLO N, Pignolet B, Brassat D, Comabella M, et al
    Reply: MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25039.
    PubMed     Text format    


    Can J Neurol Sci

  6. FIANDER MDJ, Bhan V, Stewart SA, Parks NE, et al
    Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab.
    Can J Neurol Sci. 2019 May 22:1-4. doi: 10.1017/cjn.2019.
    PubMed     Text format     Abstract available

  7. ATWAL A, Schabas A, Head J, Taylor C, et al
    Laboratory Monitoring Practices Among Canadian Multiple Sclerosis Clinicians.
    Can J Neurol Sci. 2019 May 21:1-5. doi: 10.1017/cjn.2019.
    PubMed     Text format     Abstract available


    J Clin Invest

  8. KAUSHIK DK, Bhattacharya A, Mirzaei R, Rawji KS, et al
    Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.
    J Clin Invest. 2019;130.
    PubMed     Text format     Abstract available


    J Neurol

  9. DUDEK MIR, Thies K, Kammenhuber S, Bosel J, et al
    HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.
    J Neurol. 2019 May 21. pii: 10.1007/s00415-019-09391.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: